With appropriate oversight by regulatory authorities, professional organizations such as ASCO, and patient and clinician education programs, we will see the potential for considerable cost savings and increased access and equity of cancer care through the use of biosimilars.
In 2015, ASCO and AACI led a multi-stakeholder survey to identify and prioritize the most burdensome regulatory and/or administrative aspects of clinical trials: clinical trial contracting, clinical trial coverage analyses and budgeting, and training and regulatory requirements.
Researchers overseeing the trial at Roswell Park discuss the effectiveness of CIMAvax-EGF in NSCLC, the results of completed clinical trials in Cuba, and the long-term plans for additional testing of the vaccine.
Dr. Michael P. Link is the recipient of the 2017 Pediatric Oncology Award in recognition of his dedication to advancing the field of pediatric oncology by finding new strategies in the management of common childhood cancers.
Stephen A. Cannistra, MD, FASCO, editor-in-chief of the Journal of Clinical Oncology (JCO) and professor of medicine at Harvard Medical School, will speak about “The Peer-Review Process and Writing an Outstanding Manuscript."